News FDA ramps up unannounced inspections of foreign facilities Trump orders the FDA to ease the commissioning of domestic manufacturing facilities, as the regulator announces more unannounced foreign inspections.
Digital How to fix pharma's content duplication problem At the heart of every pharma company lies a big problem: medical affairs and commercial teams are independently creating the same content.
R&D Quality compliance in the digital era Quality compliance in the pharma industry is foundational to guaranteeing safe and effective products.
Sales & Marketing Sponsored 12 Questions with Jackie Marchington Jackie Marchington is Head of Compliance and Ethics for IPG Health Medical Communications.
Sales & Marketing Eliminate swivel chair processes to streamline claims manage... Healthcare professionals (HCPs) rely on biopharma companies for accurate drug information. Out-of-date claims can damage both brand reputation and industry credibility.
Sales & Marketing Sponsored Ensuring compliance - The Functional Point of Contact (FPOC)... As has been widely acknowledged, one of the most meaningful steps a business can take is to establish a
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.